Terizidone is a second-line antitubercular agent and a cycloserine derivative primarily utilized in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. As an effective therapeutic… Read more
Terizidone is a second-line antitubercular agent and a cycloserine derivative primarily utilized in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. As an effective therapeutic option when first-line medications are insufficient, it functions by inhibiting bacterial cell wall synthesis. Laboratories and pharmaceutical researchers rely on high-quality reference standards of Terizidone API, alongside its specific impurities and stable isotope-labelled compounds, to support rigorous scientific work. These analytical tools are essential for precise impurity profiling, method validation, and ongoing quality control throughout the drug development lifecycle. By providing consistent materials for comparative studies, these labelled isotopologues and related compounds enable accurate identification and quantification, ensuring that pharmaceutical formulations meet required safety and efficacy benchmarks. This category provides the necessary standards to facilitate critical research into the pharmacology and regulatory compliance of this vital antibiotic treatment.